Today: 7 February 2026
Subscribe
Browse Category

Healthcare Stocks News 27 December 2025 - 18 January 2026

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson shares closed down 0.4% at $218.66 Friday ahead of the Martin Luther King Jr. Day market holiday. The S&P 500 health care sector fell 0.8%. J&J reports fourth-quarter results Wednesday, Jan. 21, with investors focused on earnings and 2026 guidance. The NYSE will reopen Tuesday after the holiday.
18 January 2026
··········
Johnson & Johnson stock price: 3 things to watch before JNJ earnings after Friday dip

Johnson & Johnson stock price: 3 things to watch before JNJ earnings after Friday dip

Johnson & Johnson shares fell 0.41% to $218.66 Friday after the company released new Phase 3 trial data for Caplyta in major depressive disorder. U.S. markets will be closed Monday for Martin Luther King Jr. Day. J&J is scheduled to report earnings Jan. 21 before the bell. The S&P 500 ended nearly flat, with healthcare stocks weighing on indexes.
17 January 2026
·····
Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

New York, January 13, 2026, 12:13 PM EST — Regular session Option Care Health shares jumped nearly 10% Tuesday following the release of preliminary fourth-quarter results, a first look at its 2026 forecast, and an increase in its share buyback plan. The stock last traded up 9.7% at $35.16. The update arrives as investors scramble to gauge the year ahead for healthcare services companies reliant on volume, payer conditions, and drug mix. Option Care’s figures come out weeks before its official earnings report, with management scheduled to present at the J.P. Morgan Healthcare Conference later Tuesday. The buyback plays a
13 January 2026
·····
Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see

New York, January 12, 2026, 10:25 EST — Regular session Jaguar Health, Inc (NASDAQ: JAGX) shares dropped roughly 9% Monday after announcing a U.S. licensing deal with an affiliate of private company Future Pak, potentially generating up to $38 million for its crofelemer products. The stock last traded near $0.96, after earlier surging as much as 38%, fluctuating between $0.94 and $1.45 on about 24 million shares. Under the deal, Future Pak will hold exclusive U.S. marketing rights for Mytesi and Canalevia-CA1. Jaguar will receive an $18 million upfront fee — $16 million at closing plus $2 million contingent on
12 January 2026
···
UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

New York, Jan 5, 2026, 18:23 EST — After-hours UnitedHealth Group Inc (UNH.N) shares rose 1.7% on Monday to $342.02, after Barclays lifted its price target on the insurer. The move matters because UnitedHealth has been a re-rating story: the stock remains far below its 52-week high and investors are looking for signs that 2026 margins can stabilize. UnitedHealth’s 52-week range is $234.60 to $606.36, underscoring how quickly sentiment has swung in the group. MarketWatch The next hard catalyst is earnings. UnitedHealth said it will release full-year 2025 results and provide 2026 financial guidance on Jan. 27 before the market
6 January 2026
·····
Johnson & Johnson stock today: JNJ nudges lower after $1.30 dividend as earnings loom

Johnson & Johnson stock today: JNJ nudges lower after $1.30 dividend as earnings loom

New York, January 2, 2026, 12:21 ET — Regular session Johnson & Johnson shares edged lower on Friday after the healthcare conglomerate declared its first-quarter dividend, leaving the stock little changed on the first trading day of 2026. Jnj The muted reaction reflects how investors use dividend announcements less as a surprise catalyst and more as a signal of steady cash returns, particularly for a large, widely held defensive name like J&J. That matters now because rate expectations often shape demand for dividend stocks: when investors expect rates to fall, a stable payout can look more attractive relative to safer
2 January 2026
·····
UnitedHealth stock rises today as UNH outpaces S&P 500 in early 2026 trade

UnitedHealth stock rises today as UNH outpaces S&P 500 in early 2026 trade

NEW YORK, Jan 2, 2026, 10:55 ET — Regular session Shares of UnitedHealth Group climbed 0.7% to $332.29 in morning trading on Friday, outperforming the broader market as the first full U.S. trading session of 2026 got underway. The move matters because UnitedHealth is heading into its late-January results with investors focused on whether the insurer can steady medical-cost trends and lay out a clearer 2026 path. The company is due to provide 2026 guidance with its full-year 2025 results later this month. UnitedHealth Group UnitedHealth has been under scrutiny after it commissioned outside reviews of parts of its health
2 January 2026
·····
Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus

Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus

NEW YORK, January 1, 2026, 10:07 ET — Market closed Disc Medicine, Inc. shares rose 3.3% to $79.41 in the last U.S. trading session of 2025, before Wall Street shut on Thursday for the New Year’s Day holiday. Investors are focused on a U.S. Food and Drug Administration decision expected by the end of January on Disc’s lead drug candidate bitopertin for erythropoietic protoporphyria, or EPP, a rare genetic disease in which light exposure can trigger severe pain. Investing.com Australia The ruling is being watched beyond Disc because bitopertin is among the early drugs tapped for the FDA’s Commissioner’s National
1 January 2026
·····
AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

NEW YORK, December 31, 2025, 05:02 ET — Premarket Aimei Health Technology Co., Ltd shares rose 38% to $114 in premarket trading on Wednesday, extending Tuesday’s outsized move in the Nasdaq-listed blank-check company. The stock ended the prior session up 89% at $82.58 after trading in a wide range. StockAnalysis The spike matters because Aimei’s share count shrank sharply after recent redemptions, a setup that can amplify price swings when even modest buying hits a thin market. In a Dec. 2 filing, the company said shareholders redeemed 3,942,661 public shares for about $44.8 million, and that it would have about
31 December 2025
····
Abbott stock today: ABT rises as Exact Sciences deal filing and Volt AFib device stay in focus

Abbott stock today: ABT rises as Exact Sciences deal filing and Volt AFib device stay in focus

NEW YORK, December 30, 2025, 19:51 ET — After-hours Abbott Laboratories (ABT.N) shares rose 0.97% to $125.78 in Tuesday’s regular session and held steady in after-hours trading. ABT quote The move lands as investors reprice 2026 catalysts for large-cap healthcare, where product cycles and deal timelines can matter more than day-to-day macro noise. Abbott has two big threads in play: a planned push deeper into cancer screening through a major acquisition and a newly cleared heart-rhythm device in a fast-developing market. Both can influence revenue mix and margins, which feed directly into valuation. In the broader tape, U.S. stocks ended
31 December 2025
····
Boston Scientific (BSX) stock slips in year-end pullback; February earnings loom

Boston Scientific (BSX) stock slips in year-end pullback; February earnings loom

NEW YORK, December 29, 2025, 10:27 PM ET — Market closed Boston Scientific shares closed down 0.3% at $95.76 on Monday. The stock traded between $95.53 and $96.64, with about 5.4 million shares changing hands. StockAnalysis The modest move still matters now because thin year-end liquidity can magnify small shifts in positioning. For large-cap healthcare names like Boston Scientific, traders are also watching whether defensive sectors can stay steady as leadership narrows in the final stretch of 2025. Wall Street’s main indexes finished lower, with the Dow down 0.51%, the S&P 500 off 0.35% and the Nasdaq down 0.50%, according
30 December 2025
·····
Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

Medtronic (MDT) Stock: Dividend Timing, MiniMed IPO Watch, and What to Know Before the Next NYSE Session

NEW YORK, Dec. 27, 2025, 4:10 p.m. ET — Market Closed (Weekend) Medtronic plc (NYSE: MDT) heads into the weekend with investors balancing a quiet, year-end tape against several company-specific narratives that still matter for 2026: a freshly passed dividend record window, the planned separation of its diabetes business via the MiniMed IPO process, and continued focus on cardiovascular momentum that has helped drive the stock’s 2025 run. With U.S. markets shut until Monday’s open, the immediate question for shareholders isn’t what MDT did minute-to-minute on Saturday—because it didn’t trade—but what the stock’s latest positioning says about sentiment, and what
27 December 2025
·····
1 2 3 4 … 6

Stock Market Today

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop